• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Descriptive Analysis of Mortality Predictors in H1n1 Influenza in South Indian Patients

tetano

Editor, Senior Moderator
Infect Disord Drug Targets. 2017 Apr 7. doi: 10.2174/1871526517666170407155558. [Epub ahead of print]
[h=1]Descriptive Analysis of Mortality Predictors in H1n1 Influenza in South Indian Patients.[/h] Khera K[SUP]1[/SUP], Singh A[SUP]2[/SUP], Thunga G[SUP]1[/SUP], Agarwal J[SUP]1[/SUP], Awasthi S[SUP]1[/SUP], Francis JM[SUP]1[/SUP], Bhat R[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] H1N1 (hemagglutinin-H-neuroaminidase-N) influenza infection is associated with high morbidity and mortality because of associated complications and related factors. Predictors of mortality in H1N1 patients are studied with very few without seasonal/pandemic declaration. This study was carried out to describe the clinical features, complications and different risk factors that affect the outcome in the patients with confirmed H1N1influenza infection.
[h=4]METHODS:[/h] A retrospective study was done in Kasturba Medical College Hospital, Manipal, India by analyzing the medical records of 141 patients admitted from January, 2011 to June, 2015.
[h=4]RESULTS:[/h] Of the 141 patients in the study, 51.1% of the patients were female with a mean age of 32?16.2 years. Fever with headache was observed in 92.9% patients while cough in 78.7% patients and breathlessness in 54.6% patients. On the basis of disease severity, 53.2% of the patients were put on mechanical ventilation. For all the patients, treatment for influenza management began with oseltemivir. Diuretics, anti-anxiety and corticosteroids were given as supportive and symptomatic care which contributed to high mortality in hospitalized patients. Mean hospitalization period was 8.5 days. During the hospitalization, patients developed different complications, like (31.20%) patients developed respiratory tract infections, while (17.7%) patients developed ARDS (17.7%) and (14.4%) patients developed sepsis (14.4%). The mortality rate of this study population was found to be 29.1 %.
[h=4]CONCLUSION:[/h] It was observed that low oxygen saturation during admission, high blood urea level, use of diuretics, corticosteroids, anti-anxiety drugs and complications like ARDS, sepsis influence the mortality rate of patients with H1N1 infection.
Copyright? Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.


[h=4]KEYWORDS:[/h] Acute respiratory distress syndrome; Corticosteroids ; Multiple organs dysfunction syndrome; Swine flu; Viral infection in India

PMID: 28403799 DOI: 10.2174/1871526517666170407155558
 
Back
Top Bottom